NCT05305261 is a clinical trial in Antibody, sponsored by National University of Malaysia.

Who is sponsoring NCT05305261?

NCT05305261 is sponsored by National University of Malaysia.

What condition does NCT05305261 study?

NCT05305261 studies Antibody, Vaccine, Maternal, Cord.

Is NCT05305261 still recruiting?

NCT05305261 is currently completed. Last updated 8 April 2022.

Last reviewed 2022-04-08 · How we verify

NCT05305261

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.

Completed Last updated 8 April 2022

What this trial tests

trial in Antibody in 197 participants. Completed in 18 March 2022.

Timeline

29 July 2021

Primary endpoint
18 March 2022

18 March 2022

Quick facts

Lead sponsor	National University of Malaysia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	197
Start date	29 July 2021
Primary completion	18 March 2022
Estimated completion	18 March 2022
Sites	1 location across Malaysia

Conditions studied

Antibody — all drugs for Antibody →
Vaccine — all drugs for Vaccine →
Maternal — all drugs for Maternal →
Cord — all drugs for Cord →

Sponsor

National University of Malaysia

Who can join

Adults 18 to 50, any sex, with Antibody or Vaccine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective clinical study aiming to investigate on the transplacental antibody transmission post Covid-19 infection during pregnancy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Antibody

Currently open trials in the same condition.

NCT06482801 — Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT · Phase 2 · recruiting
NCT06168032 — COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research · NA · recruiting

Other National University of Malaysia trials

Trials by the same sponsor.

NCT07251842 — Metabolic Availability of Methionine in Tempeh Chips Among Reproductive-age Women Using Indicator Amino Acid Oxidation ( · NA · not yet recruiting
NCT07362394 — Autologous Dentine Graft Compared to Xenograft in Managing Periodontally Compromised Second Molar After Third Molar Remo · NA · not yet recruiting
NCT07503223 — Sleep Optimization With Acoustic Therapy · NA · recruiting
NCT07432373 — Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection · not yet recruiting
NCT07157397 — Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05305261 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National University of Malaysia
Last refreshed: 8 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05305261.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing